Neuroscience Training Program, University of Wisconsin-Madison, Madison, Wisconsin 53719, USA.
J Neurosci. 2011 Mar 2;31(9):3249-60. doi: 10.1523/JNEUROSCI.2050-10.2011.
Frontal cortical regions are activated by food-associated stimuli, and this activation appears to be dysregulated in individuals with eating disorders. Nevertheless, frontal control of basic unconditioned feeding responses remains poorly understood. Here we show that hyperphagia can be driven by μ-opioid receptor stimulation in restricted regions of ventral medial prefrontal cortex (vmPFC) and orbitofrontal cortex. In both ad libitum-fed and food-restricted male Sprague Dawley rats, bilateral infusions of the μ-opioid agonist [d-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin (DAMGO) markedly increased intake of standard rat chow. When given a choice between palatable fat-enriched versus carbohydrate-enriched test diets, intra-vmPFC DAMGO infusions selectively increased carbohydrate intake, even in rats with a baseline fat preference. Rats also exhibited motor hyperactivity characterized by rapid switching between brief bouts of investigatory and ingestive behaviors. Intra-vmPFC DAMGO affected neither water intake nor nonspecific oral behavior. Similar DAMGO infusions into neighboring areas of lateral orbital or anterior motor cortex had minimal effects on feeding. Neither stimulation of vmPFC-localized δ-opioid, κ-opioid, dopaminergic, serotonergic, or noradrenergic receptors, nor antagonism of D1, 5HT1A, or α- or β-adrenoceptors, reproduced the profile of DAMGO effects. Muscimol-mediated inactivation of the vmPFC, and intra-vmPFC stimulation of κ-opioid receptors or blockade of 5-HT2A (5-hydroxytryptamine receptor 2A) receptors, suppressed motor activity and increased feeding bout duration-a profile opposite to that seen with DAMGO. Hence, μ-opioid-induced hyperphagia and carbohydrate intake can be elicited with remarkable pharmacological and behavioral specificity from discrete subterritories of the frontal cortex. These findings may have implications for understanding affect-driven feeding and loss of restraint in eating disorders.
额皮质区域被与食物相关的刺激激活,而这种激活在饮食失调个体中似乎失调。然而,对于基本无条件进食反应的额皮质控制仍知之甚少。在这里,我们表明,在腹内侧前额皮质(vmPFC)和眶额皮质的受限区域中,μ-阿片受体刺激可驱动过度进食。在自由进食和食物限制的雄性 Sprague Dawley 大鼠中,双侧注射μ-阿片激动剂[d-Ala2,N-Me-Phe4,Gly5-ol]-脑啡肽(DAMGO)可显著增加标准大鼠饲料的摄入量。当大鼠在美味的高脂肪与高碳水化合物饮食之间进行选择时,vmPFC 内的 DAMGO 输注选择性地增加了碳水化合物的摄入量,即使在具有基线脂肪偏好的大鼠中也是如此。大鼠还表现出运动性多动,其特征是快速在短暂的探究和摄取行为之间切换。vmPFC 内的 DAMGO 输注既不影响水的摄入,也不影响非特异性的口腔行为。类似地,向外侧眶额或前运动皮质的邻近区域进行 DAMGO 输注对进食的影响很小。vmPFC 定位的 δ-阿片、κ-阿片、多巴胺能、5-羟色胺能或去甲肾上腺素能受体的刺激,或 D1、5HT1A、或α-或β-肾上腺素能受体的拮抗,都不能再现 DAMGO 效应的特征。vmPFC 中的 muscimol 介导失活,以及 vmPFC 内 κ-阿片受体的刺激或 5-HT2A(5-羟色胺受体 2A)受体的阻断,抑制了运动活性并增加了进食发作的持续时间-与 DAMGO 相反的模式。因此,μ-阿片诱导的过度进食和碳水化合物摄入可以从前额叶皮质的离散亚区以显著的药理学和行为特异性引起。这些发现可能对理解饮食失调中的情感驱动进食和失去克制具有启示意义。